Machine Learning Kiromic BioPharma Announces Reverse Stock Split Business Wire Mar 11, 2023 Kiromic BioPharma, a clinical-stage fully-integrated biotherapeutics company using its proprietary DIAMOND artificial intelligence and data mining…
Technology Pulmobiotics Highlights Nature Biotechnology Publication of Preclinical Data Demonstrating Clearance… AIT News Desk Jan 20, 2023 -- First ‘living medicine’ to treat antibiotic-resistant Pseudomonas aeruginosa infections in the lung, a leading cause of mortality in hospital…
Technology HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603 AIT News Desk Jan 9, 2023 HiFiBiO Therapeutics, a multinational clinical-stage biotherapeutics company, announced the U.S. Food and Drug Administration (FDA) has cleared the…
Technology PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health… AIT News Desk Dec 12, 2022 AI vocal biomarker company will use funding to accelerate its commercial growth, expand its platform into new health conditions, and enter new…
Machine Learning Generate Biomedicines Demonstrates a Novel Method of Reducing Immunogenicity through Protein… AIT News Desk Dec 8, 2022 Generate Biomedicines announced that it has published data in the peer-reviewed journal Frontiers in Immunology that demonstrate the power of the…
Life Sciences Kiromic BioPharma Pipeline to Prioritize a New Gamma Delta T-cell Product Candidate AIT News Desk Jun 22, 2022 Kiromic BioPharma, Inc. a clinical-stage biotherapeutics company using its proprietary DIAMOND AI (artificial intelligence) and data mining platform…
Healthcare Management PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults… AIT News Desk Jun 14, 2022 PureTech Health plc,a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines…
Life Sciences Kiromic BioPharma Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored… AIT News Desk Jun 8, 2022 In Vivo Preclinical Data Expected to Enable Three New IND Applications to Evaluate Company’s Gamma Delta T cell Product Candidates Procel, Isocel,…
Life Sciences Fore Biotherapeutics Appoints Matthew E. Ros as Chief Executive Officer AIT News Desk Apr 19, 2022 Matthew Ros, former EVP, Chief Strategy & Business Officer of Epizyme, joins Fore as Chief Executive Officer and Director of the Board Fore…
Life Sciences IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology… AIT News Desk Mar 29, 2022 Acquisition includes wholly owned subsidiary businesses BioKey BV and BioClue BV. Platform is based on a proprietary biological discovery…